Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China
· Delayed Price · Currency is CNY 15.32
-0.01 (-0.07%)
Mar 10, 2026, 1:15 PM CST
Cachet Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,472 | 3,769 | 4,145 | 4,198 | 4,104 | 4,116 | Upgrade
|
| Market Cap Growth | 21.28% | -9.08% | -1.25% | 2.27% | -0.28% | -12.03% | Upgrade
|
| Enterprise Value | 6,109 | 6,389 | 7,913 | 9,077 | 7,930 | 8,080 | Upgrade
|
| Last Close Price | 15.33 | 12.76 | 13.71 | 13.57 | 12.92 | 12.64 | Upgrade
|
| PE Ratio | 63.39 | 23.46 | 16.58 | 14.14 | 11.60 | 12.96 | Upgrade
|
| Forward PE | - | 11.43 | 12.96 | 12.85 | 6.92 | 6.92 | Upgrade
|
| PS Ratio | 0.22 | 0.16 | 0.14 | 0.16 | 0.16 | 0.18 | Upgrade
|
| PB Ratio | 0.73 | 0.62 | 0.68 | 0.71 | 0.73 | 0.77 | Upgrade
|
| P/TBV Ratio | 1.12 | 0.97 | 1.11 | 1.19 | 1.25 | 1.36 | Upgrade
|
| P/FCF Ratio | 4.87 | 22.85 | 2.97 | - | 6.16 | 4.80 | Upgrade
|
| P/OCF Ratio | 4.78 | 20.90 | 2.60 | - | 4.50 | 3.69 | Upgrade
|
| PEG Ratio | - | 1.63 | 6.48 | 6.42 | 0.56 | 0.56 | Upgrade
|
| EV/Sales Ratio | 0.31 | 0.27 | 0.26 | 0.35 | 0.31 | 0.35 | Upgrade
|
| EV/EBITDA Ratio | 12.85 | 10.42 | 9.13 | 9.18 | 7.12 | 6.69 | Upgrade
|
| EV/EBIT Ratio | 14.82 | 11.37 | 10.78 | 10.92 | 8.15 | 7.48 | Upgrade
|
| EV/FCF Ratio | 6.65 | 38.74 | 5.67 | - | 11.90 | 9.43 | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.47 | 0.68 | 0.74 | 0.76 | 0.77 | Upgrade
|
| Debt / EBITDA Ratio | 4.35 | 4.18 | 4.39 | 4.13 | 3.65 | 3.24 | Upgrade
|
| Debt / FCF Ratio | 2.25 | 17.38 | 2.95 | - | 6.44 | 4.76 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | 0.11 | 0.20 | 0.37 | 0.35 | 0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.10 | 1.05 | 1.42 | 2.21 | 1.75 | 1.71 | Upgrade
|
| Net Debt / FCF Ratio | -0.04 | 3.90 | 0.88 | -6.21 | 2.93 | 2.40 | Upgrade
|
| Asset Turnover | 1.47 | 1.54 | 1.78 | 1.67 | 1.76 | 1.71 | Upgrade
|
| Inventory Turnover | 7.01 | 8.46 | 10.69 | 9.89 | 11.19 | 9.93 | Upgrade
|
| Quick Ratio | 1.29 | 1.21 | 1.15 | 1.10 | 1.16 | 1.16 | Upgrade
|
| Current Ratio | 1.81 | 1.66 | 1.44 | 1.44 | 1.47 | 1.46 | Upgrade
|
| Return on Equity (ROE) | 2.48% | 5.29% | 6.27% | 8.09% | 10.96% | 11.53% | Upgrade
|
| Return on Assets (ROA) | 1.90% | 2.25% | 2.72% | 3.30% | 4.19% | 4.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.21% | 4.67% | 6.45% | 7.68% | 9.49% | 10.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.60% | 9.10% | 11.70% | 13.50% | 16.50% | 19.50% | Upgrade
|
| Earnings Yield | 1.59% | 4.26% | 6.03% | 7.07% | 8.62% | 7.72% | Upgrade
|
| FCF Yield | 20.53% | 4.38% | 33.68% | -8.38% | 16.23% | 20.82% | Upgrade
|
| Dividend Yield | 1.11% | 1.33% | 1.90% | 2.28% | 2.86% | 2.61% | Upgrade
|
| Payout Ratio | 211.87% | 104.30% | 85.72% | 95.07% | 68.57% | 91.04% | Upgrade
|
| Buyback Yield / Dilution | -1.01% | -0.47% | 0.12% | 0.46% | -0.38% | -11.60% | Upgrade
|
| Total Shareholder Return | 0.09% | 0.87% | 2.02% | 2.74% | 2.49% | -8.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.